RAFAEL VALVERDE Rafael lives with obesity Mexico Novo Nordisk – a focused healthcare company Investor presentation First nine months of 2025 2 Novo Nordisk® Investor presentation First nine months of 2025 Agenda Progress on Strategic Aspirations 2025 Financials Innovation and therapeutic focus Commercial execution Agenda 3 Novo Nordisk® Investor presentation First nine months of 2025 Forward-looking statements Novo Nordisk's statutory Annual Report 2024, Form 20-F, any quarterly financial reports, investor ...